Michele Falda
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.
Journal: Bone marrow transplantation
Published: September 27, 2016
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 15, 2015
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Journal: Blood
Published: February 22, 2014
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
Journal: Journal of chemotherapy (Florence, Italy)
Published: October 01, 2013
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Journal: American journal of hematology
Published: March 30, 2013
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: November 30, 2012
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
Journal: Blood
Published: December 15, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026